Portable Noninvasive Positive Airway Device for COPD Patient Therapy

NIH RePORTER · NIH · R44 · $251,772 · view on reporter.nih.gov ↗

Abstract

Abstract Koronis Biomedical Technologies proposes to develop and fully evaluate a novel, on-demand handheld bi-level positive airway pressure (BiPAP) ventilator to treat Chronic Obstructive Pulmonary Disease (COPD) patients suffering from exertional dyspnea (“breathlessness”). It is well known that dyspnea trends severe COPD patients as they age towards inactivity, resulting in peripheral muscle deconditioning that further increases the risk of experiencing dyspnea, establishing a vicious cycle of recurrent fear of dyspnea, further inactivity and potential social isolation. The proposed Bi-level Rapid Emergency Airway THErapy (BREATHE) system will be optimized to provide proven BiPAP therapy to rapidly relieve acute dyspnea in a miniaturized, portable handheld form factor. This system will allow for therapy on the go, untethering the patient and increasing their confidence to engage in activities of daily living.

Key facts

NIH application ID
10081908
Project number
1R44HL154932-01
Recipient
KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT
Principal Investigator
Robert J Knuesel
Activity code
R44
Funding institute
NIH
Fiscal year
2020
Award amount
$251,772
Award type
1
Project period
2020-08-15 → 2022-07-31